Infectious complications in patients with acute heart failure – an overview

Czech version

Authors: J. Pařenica ¹; M. Hanslianová ^2,3
Authors‘ workplace: Interní kardiologická klinika LF MU a FN Brno ¹; Lékařská fakulta MU, Brno ²; Oddělení klinické mikrobiologie, FN Brno ³
Published in: Kardiol Rev Int Med 2016, 18(1): 18-21
Category: Cardiology Review

Overview

Infection is considered to be a trigger factor leading to acute decompensation of chronic heart failure in about 17% of hospitalised patients. Simultaneously, infection may complicate the course of hospitalisation of acute heart failure patients, and in cardiogenic shock patients this can be up to 65% of cases. The article gives an overview of the most common pathogens of community and nosocomial infections of the respiratory and urinary tract and the possibilities of their diagnosis and treatment.

Keywords:
acute heart failure – infection – procalcitonin

Sources

1. McMurray JJ, Adamopoulos S, Anker SD et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012. Eur Heart J 2012; 33: 1787– 1847. doi: 10.1093/ eurheartj/ ehs104.

2. Nieminen MS, Brutsaert D, Dickstein K et al. EuroHeart Failure Survey II (EHFS II): a survey on hospitalized acute heart failure patients: description of population. Eur Heart J 2006; 27: 2725– 2736. doi: 10.1093/ eurheartj/ ehl193.

3. Spinar J, Parenica J, Vitovec J et al. Baseline characteristics and hospital mortality in the Acute Heart Failure Database (AHEAD) Main registry. Crit Care 2011; 15: R291. doi: 10.1186/ cc10584.

4. Kohsaka S, Menon V, Iwata K et al. Microbiological profile of septic complication in patients with cardiogenic shock following acute myocardial infarction (from the SHOCK study). Am J Cardiol 2007; 99: 802– 804. doi: 10.1016/ j.amjcard.2006.10.040.

5. Kohsaka S, Menon V, Lowe AM et al. Systemic inflammatory response syndrome after acute myocardial infarction complicated by cardiogenic shock. Arch Intern Med 2005; 165: 1643– 1650. doi: 10.1001/ archinte.165.14.1643.

6. Thiele H, Zeymer U, Neumann FJ et al. Intraaortic balloon support for myocardial infarction with cardiogenic shock. N Engl J Med 2012; 367: 1287– 1296. doi: 10.1056/ NEJMoa1208410.

7. Thiele H, Zeymer U, Neumann FJ et al. Intra-aortic balloon counterpulsation in acute myocardial infarction complicated by cardiogenic shock (IABP-SHOCK II): final 12 month results of a randomised, open-label trial. Lancet 2013; 382: 1638– 1645. doi: 10.1016/ S0140-6736(13)61783-3.

8. Schmidt M, Bréchot N, Hariri S et al. Nosocomial infections in adult cardiogenic shock patients supported by venoarterial extracorporeal membrane oxygenation. Clin Infect Dis 2012; 55: 1633– 1641. doi: 10.1093/ cid/ cis783.

9. Perbet S, Mongardon N, Dumas F et al. Early-onset pneumonia after cardiac arrest: characteristics, risk factors and influence on prognosis. Am J Respir Crit Care Med 2011; 184: 1048– 1054. doi: 10.1164/ rccm.201102-0331OC.

10. Melsen WG, Rovers MM, Koeman M et al. Estimating the attributable mortality of ventilator-associated pneumonia from randomized prevention studies. Crit Care Med 2011; 39: 2736– 2742. doi: 10.1097/ CCM.0b013e3182281f33.

11. Kubková L, Spinar J, Pávková Goldbergová M et al. Inflammatory response and Creactive protein value in patient with acute coronary syndrome. Vnitr Lek 2013; 59: 981– 988.

12. Maisel A, Neath SX, Landsberg J et al. Use of procalcitonin for the diagnosis of pneumonia in patients presenting with a chief complaint of dyspnoea: results from the BACH (Biomarkers in Acute Heart Failure) trial. Eur J Heart Fail 2012; 14: 278– 286. doi: 10.1093/ eurjhf/ hfr177.

13. Demissei BG, Cleland JG, O’Connor CM et al. Procalcitonin-based indication of bacterial infection identifies high risk acute heart failure patiens. Int J Cardiol 2016; 204: 164– 171. doi: 10.1016/ j.ijcard.2015.11.141.

14. Nair GB, Niederman MS. Ventilator-associated pneumonia: present understanding and ongoing debates. Intensive Care Med 2015; 41: 34– 48. doi: 10.1007/ s00134-014-3564-5.